Articles Related to Immunochemistry

Posted from Discovering Biology in a Digital World by Todd Smith on Fri May 03, 2019

Immunoproteosome

In early April 2019, the Institute for Systems Biology (ISB, Settle WA) hosted its 18th annual symposium. This year's theme focused on translational biology, which is the practice of commercializing research discovery. Over the two-day symposium, the audience was informed about the latest in the research and development of new products for fighting cancer with immunotherapy and combating research to ... Read more

Posted from Discovering Biology in a Digital World by Todd Smith on Wed Dec 05, 2018

Immunoprofiling sample preparation

As previously discussed , immunoprofiling is the quantitative measurement of antigen receptors (ARs; antibodies or T-cell receptors) in a sample. Massively parallel (NextGen) DNA sequencing is a commonly used method for this purpose because receptor diversity can be quickly and cost-effectively measured with the added benefit that individual receptors can be quantified.

AR diversity is a ... Read more

Posted from Discovering Biology in a Digital World by Todd Smith on Tue Jul 10, 2018

Infographic: BCRs vs TCRs

Scientists, and science editors love acronyms. While they can be obfuscating, they help reduce cumbersome language.

For many years the term antibody was commonly abbreviated as Ab (Ig and others too). As high-throughput DNA sequencing has become a standard way to measure antibody and T cell receptor profiles it has also become common to compare these ... Read more

By: Sean Maden

The requirements of "good communication skills" and "comfortable working in a multidisciplinary setting" on a biotech job listing are common, but what do these mean in practice? For work in biotech, there's often more than meets the eye in a job posting.

Biotechnology is an inherently multidisciplinary field, now more so than ever. A single lab can employ personnel ... Read more

By: Sean Maden

The biotech industry is booming. Some reservations notwithstanding, influxes of venture capital reflect economic robustness in the biotech market, and the recent pledge of funds for personalized (or "precision") medical research by the Obama administration reflect widespread public interest in the industry.

Amidst this upswing, many are still hesitant to call Seattle a biotech hub. This is for several ... Read more